About Knopp Biosciences
The mission of Knopp Biosciences is to discover, develop, and deliver breakthrough medicines for devastating diseases and to improve global access to health care.
We predicate our work on the value of collaboration, the fundamentals of quality and safety, and an unwavering commitment to our patients, partners, shareholders, community, and colleagues.
Our research has led to an investigational compound in clinical development for ALS immunological disorders, as well as discovery platforms directed to small molecule mediators of epilepsy and neuropathic pain.
Days count for people with devastating diseases. That’s why we bring unmatched energy and a new level of collaboration with practitioners, investigators, and pharmaceutical companies in bridging the distance from the laboratory to the bedside.
Knopp's pipeline consists of investigational drug products that have not been approved by the U.S. Food and Drug Administration. These investigational drug products are still undergoing clinical study to verify their safety and effectiveness.